Search results for " multiple"

showing 10 items of 903 documents

Synchronous parenchymal renal tumors of different histology in the same kidney

2009

Background: Synchronous primary cortical tumors of different histology in the same kidney are rare. Preoperative awareness of this coexistence is important, since it can help in planning the surgical approach. Purpose: To describe the imaging findings observed in five patients with two parenchymal malignant tumors of different histology in the same kidney. Material and Methods: We reviewed the pathology reports of 381 patients operated for renal tumors from January 2000 to March 2007. The medical records of all patients with multiple, synchronous, primary lesions of different histology in the same kidney were reviewed with special attention to imaging findings and indications on the nature…

AdultMalemedicine.medical_specialtyPathologyContrast MediaRenal tumorImagingDifferent subtypeNeoplasms Multiple PrimaryRetrospective StudieParenchymaCarcinomamedicineHumansRadiology Nuclear Medicine and imagingCarcinoma Renal CellRetrospective StudiesAgedAged 80 and overKidneyRadiological and Ultrasound Technologybusiness.industryMedical recordMultifocalityKidney NeoplasmHistologyRetrospective cohort studyGeneral MedicineMiddle Agedmedicine.diseaseKidney NeoplasmsCarcinoma Papillarymedicine.anatomical_structureAdenocarcinomaFemaleRadiologybusinessTomography X-Ray ComputedKidney diseaseAdenocarcinoma Clear CellHuman
researchProduct

Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis.

2017

PURPOSE: Multiple sclerosis (MS) has been proposed as a possible differential diagnosis for Fabry disease (FD). The aim of this work was to evaluate the involvement of corpus callosum (CC) on MR images and its possible role as a radiological sign to differentiate between FD and MS. METHODS: In this multicentric study, we retrospectively evaluated the presence of white matter lesions (WMLs) on the FLAIR images of 104 patients with FD and 117 patients with MS. The incidence of CC-WML was assessed in the two groups and also in a subgroup of 37 FD patients showing neurological symptoms. RESULTS: WMLs were detected in 50 of 104 FD patients (48.1%) and in all MS patients. However, a lesion in the…

AdultMalemedicine.medical_specialtyPathologyNeurologySettore MED/09 - Medicina InternaAdolescentCorpus callosumFluid-attenuated inversion recoveryCorpus callosumCorpus callosum; Fabry disease; MRI; Multiple sclerosis030218 nuclear medicine & medical imagingDiagnosis DifferentialMultiple sclerosis03 medical and health sciences0302 clinical medicinemedicineHumansRadiology Nuclear Medicine and imagingAgedRetrospective StudiesNeuroradiologyFabry diseasebusiness.industryMultiple sclerosisMiddle Agedmedicine.diseaseMagnetic Resonance ImagingFabry diseaseHyperintensityCorpus callosum; Fabry disease; MRI; Multiple sclerosis.FemaleNeurology (clinical)RadiologyDifferential diagnosisCardiology and Cardiovascular Medicinebusiness030217 neurology & neurosurgeryMRI
researchProduct

A pooled analysis of cigarette smoking and risk of multiple myeloma from the international multiple myeloma consortium.

2015

Abstract Background: Past investigations of cigarette smoking and multiple myeloma have been underpowered to detect moderate associations, particularly within subgroups. To clarify this association, we conducted a pooled analysis of nine case–control studies in the International Multiple Myeloma Consortium, with individual-level questionnaire data on cigarette smoking history and other covariates. Methods: Using a pooled population of 2,670 cases and 11,913 controls, we computed odds ratios (OR) and 95% confidence intervals (CI) relating smoking to multiple myeloma risk using unconditional logistic regression adjusting for gender, age group, race, education, body mass index, alcohol consump…

AdultMalemedicine.medical_specialtyPathologySmoking - multiple myelomaAdolescentEpidemiologyPopulationLogistic regressionArticleYoung AdultRisk FactorsInternal medicineSurveys and QuestionnairesMedicineHumansRisk factoreducationMultiple myelomaeducation.field_of_studybusiness.industryConfoundingSmokingCase-control studyOdds ratioMiddle Agedmedicine.diseaseOncologyCase-Control StudiesFemalebusinessMultiple MyelomaBody mass indexCancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
researchProduct

Three years of experience : the Italian registry and safety data update

2011

At the end of 2006, a pharmacovigilance program on natalizumab was settled by the Italian Pharmaceutical Agency, and on January 2007, multiple sclerosis patients poorly responding to the immunomodulating therapies or with an aggressive clinical form of disease from onset initiated to be registered and to receive the medication. On February 2010, almost 3,000 cases have been treated with natalizumab. The drop-out rate is 10%. Almost 800 cases received cycles of natalizumab for more than 18 months. One case of PML was reported and other adverse events are similar to those described in phase III studies. The majority of cases remained stable, while in 25% of cases, an improvement of disability…

AdultMalemedicine.medical_specialtyPediatricsMultiple SclerosisDermatologyDiseaseAntibodies Monoclonal HumanizedNatalizumabPharmacovigilanceProduct Surveillance PostmarketingmedicineHumansRegistriesAdverse effectbusiness.industryNatalizumabMultiple sclerosisGeneral Medicinemedicine.diseasePsychiatry and Mental healthItalyPHARMACOVIGILANCEREGISTRYsurveillance program; pharmacovigilance; multiple sclerosis; natalizumabPhysical therapyFemaleSettore MED/26 - NeurologiaNeurology (clinical)NeurosurgerybusinessMultiple sclerosis NatalizumabSurveillance program Pharmacovigilancemedicine.drug
researchProduct

Improvements achieved in an oocyte donation program over a 10-year period: sequential increase in implantation and pregnancy rates and decrease in hi…

2006

Objective To compare outcome parameters and cumulative pregnancy rates (PRs) in oocyte donation cycles over a period of 10 years. Design Retrospective study. Setting University-affiliated assisted reproductive technology program. Patient(s) Women undergoing oocyte donation (10,537 cycles) between 1995 and 2005. Intervention(s) Ovarian stimulation and oocyte retrieval in donors. Embryo transfer performed in recipients after endometrial preparation. Main Outcome Measure(s) Outcome parameters and cumulative PRs were calculated and compared in relation to indication, age, and origin of sperm used. Result(s) Overall PR, implantation rate, clinical PR, and miscarriage rate per embryo transfer per…

AdultMalemedicine.medical_specialtyPregnancy Ratemedicine.medical_treatmentBiologyInseminationMiscarriageAge DistributionPregnancymedicineHumansEmbryo ImplantationRetrospective StudiesGynecologyPregnancyAssisted reproductive technologyOocyte DonationObstetricsObstetrics and GynecologyMiddle AgedOocytemedicine.diseaseSpermEmbryo transferPregnancy ratemedicine.anatomical_structureReproductive MedicineFemalePregnancy MultipleFertility and Sterility
researchProduct

Effect of organizational features on patient satisfaction with care in Italian multiple sclerosis centres

2017

Background and purpose Receiving clear, complete and up-to-date information and having a satisfying relationship with the health professional (HP) are of primary importance for MS patients. Healthcare organization plays a key role in promoting an effective relationship and communication between patients and HPs. The present study aims to explore which care organization and service characteristics provided by Italian MS centres best predict patients’ satisfaction with healthcare. Methods Eighty-one centres and 707 patients (502 women, mean age 40.5 years, SD 10.2; mean education 12.2 years, SD 3.6; time since diagnosis 5.9 years, SD 1.5) were included in the analysis. The care organization a…

AdultMalemedicine.medical_specialtymedia_common.quotation_subjectPsychological interventionNicehealth professional-patient relationshipmultiple sclerosiscare organization; health professional-patient relationship; multiple sclerosis; patients’ satisfaction; psychological support03 medical and health sciences0302 clinical medicinePatient satisfactionCare organizationExcellenceSurveys and QuestionnairesHealth caremedicineHumans030212 general & internal medicinepatients’ satisfactioncomputer.programming_languagemedia_commonPhysician-Patient Relationsbusiness.industryMultiple sclerosisMiddle Agedmedicine.diseaseConfidence intervalItalyNeurologyPatient SatisfactionFamily medicineFemalecare organizationNeurology (clinical)businessDelivery of Health CareCare Organization Health professional–Patient Relationship Multiple Sclerosis Patients’ Satisfaction Psychological Supportcomputer030217 neurology & neurosurgerypsychological supportEuropean Journal of Neurology
researchProduct

Clinical experience and perinatal outcome of blastocyst transfer after coculture of human embryos with human endometrial epithelial cells: a 5-year f…

2003

Abstract Objective To evaluate the reproductive and neonatal outcome of blastocyst transfer after coculture with human endometrial epithelial cells in IVF and oocyte donation. Design Retrospective study. Setting Private assisted reproductive center. Patient(s) Two hundred sixty women undergoing IVF and 469 oocyte recipients. Intervention(s) IVF or intracytoplasmic sperm injection (ICSI) and transfer of at least one blastocyst after coculture with human endometrial epithelial cells. Main outcome measure(s) Blastocyst formation rate, implantation and pregnancy rates, neonatal outcome, and congenital birth defects. Results Among patients who had transfer with their own oocytes, 1,193 of 2,349 …

AdultMalemedicine.medical_specialtymedicine.medical_treatmentBiologyEndometriumIntracytoplasmic sperm injectionCongenital AbnormalitiesEndometriumPregnancyRisk FactorsmedicineHumansBlastocystEmbryo ImplantationSex Ratioreproductive and urinary physiologyRetrospective StudiesGynecologyPregnancyurogenital systemBlastocyst TransferPregnancy OutcomeObstetrics and GynecologyEmbryo cultureEpithelial Cellsmedicine.diseaseEmbryo TransferEmbryo MammalianEmbryo transferCoculture Techniquesmedicine.anatomical_structureReproductive Medicineembryonic structuresGestationFemalePregnancy MultipleFollow-Up StudiesFertility and sterility
researchProduct

Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis

2020

Abstract An ever-expanding number of disease-modifying drugs for multiple sclerosis have become available in recent years, after demonstrating efficacy in clinical trials. In the real-world setting, however, disease-modifying drugs are prescribed in patient populations that differ from those included in pivotal studies, where extreme age patients are usually excluded or under-represented. In this multicentre, observational, retrospective Italian cohort study, we evaluated treatment exposure in three cohorts of patients with relapsing-remitting multiple sclerosis defined by age at onset: paediatric-onset (≤18 years), adult-onset (18–49 years) and late-onset multiple sclerosis (≥50 years). We…

AdultMalemedicine.medical_specialtyneuroinflammationCohort Studies03 medical and health sciences0302 clinical medicineMultiple Sclerosis Relapsing-RemittingInternal medicinemedicineHumansDisabled Persons030212 general & internal medicineProspective StudiesRisk factorclinical trials; clinically isolated syndrome; demyelination; multiple sclerosis epidemiology; neuroinflammationRetrospective Studiesclinical trialsClinically isolated syndromeExpanded Disability Status ScaleProportional hazards modelbusiness.industryHazard ratioMiddle AgedItalyAntirheumatic Agentsclinically isolated syndromeCohortDisease Progressionmultiple sclerosis epidemiologySettore MED/26 - NeurologiaFemaleNeurology (clinical)demyelinationAge of onsetbusiness030217 neurology & neurosurgeryCohort studyFollow-Up Studies
researchProduct

Grey matter damage and overall cognitive impairment in primary progressive multiple sclerosis

2011

Objectives: To identify associations between cognitive impairment and imaging measures in a cross-sectional study of patients with primary progressive multiple sclerosis (PPMS). Methods: Neuropsychological tests were administered to 27 patients with PPMS and 31 controls. Patients underwent brain conventional magnetic resonance imaging (MRI) sequences, volumetric scans and magnetization transfer (MT) imaging; MT ratio (MTR) parameters, grey matter (GM) and normal-appearing white matter (NAWM) volumes, and WM T2 lesion load (T2LL) were obtained. In patients, multiple linear regression models identified the imaging measure associated with the abnormal cognitive tests independently from the ot…

AdultMalemedicine.medical_specialtyprimary progressive multiple sclerosisAudiologyGrey matterNeuropsychological TestsWhite matterExecutive FunctionCognitionMemoryPredictive Value of TestsLondonmedicineHumansAttentionEffects of sleep deprivation on cognitive performanceAgedChi-Square Distributionmedicine.diagnostic_testSettore M-PSI/02 - Psicobiologia E Psicologia FisiologicaVerbal BehaviorMultiple sclerosisNeuropsychologyBrainCognitionMagnetic resonance imagingMiddle AgedMultiple Sclerosis Chronic Progressivemedicine.diseaseMagnetic Resonance ImagingCognitive testmedicine.anatomical_structureCross-Sectional StudiesNeurologyCase-Control StudiesLinear ModelsFemaleNeurology (clinical)PsychologyCognition DisordersNeuroscience
researchProduct

Self-Other Differentiation Scale: Dimensionality, IRT Parameterization, and Measurement Invariance

2018

The Self-Other Differentiation Scale (Olver, Aries, & Batgos, 1989) is a self-report instrument assessing the experience of a separate sense of self from others. The authors aimed to examine its dimensionality, reliability, and measurement invariance across gender. It was completed by 348 participants (48% men) from 17 to 30 years old in Study 1, 348 participants (40% men) from 18 to 28 years old in Study 2, and 1,068 participants (49% men) from 17 to 28 years old in Study 3. The results supported the hypothesis of just one factor underlying the scale; they also showed an appropriate internal consistency and a partial measurement invariance across gender. Results also showed evidence fo…

AdultMalescale validationAdolescentPsychometricsScale (ratio)PsychometricsSelf-conceptPsychology of self050109 social psychologyself-other differentiationMeasurement invariance; multiple-group categorical confirmatory factor analysis; scale validation; self-other differentiation; Developmental and Educational Psychology; Clinical Psychology; Life-span and Life-course StudiesYoung Adult0504 sociologyDevelopmental and Educational PsychologyHumans0501 psychology and cognitive sciencesMeasurement invarianceLife-span and Life-course StudiesReliability (statistics)Measurement invariancemultiple-group categorical confirmatory factor analysis05 social sciencesSelf otherReproducibility of Results050401 social sciences methodsSelf ConceptClinical PsychologyFemaleSelf ReportPsychologyCognitive psychologyCurse of dimensionalityThe Journal of Genetic Psychology
researchProduct